Louisiana State Employees Retirement System’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33,600
Closed -$90K 1511
2022
Q4
$90K Sell
33,600
-200
-0.6% -$583 ﹤0.01% 1503
2022
Q3
$110K Buy
33,800
+3,200
+10% +$14.5K ﹤0.01% 1489
2022
Q2
$162K Hold
30,600
﹤0.01% 1490
2022
Q1
$230K Buy
30,600
+100
+0.3% +$774 0.01% 1483
2021
Q4
$282K Buy
30,500
+100
+0.3% +$1.06K 0.01% 1464
2021
Q3
$433K Buy
30,400
+7,800
+35% +$121K 0.01% 1347
2021
Q2
$376K Buy
+22,600
New +$421K 0.01% 1387

Other funds holding ORGO

Louisiana State Employees Retirement System's ORGO Position: Q1 2023 in Review

Louisiana State Employees Retirement System sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 33,600 shares — an estimated $90K sold.

Louisiana State Employees Retirement System first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $433K in Q3 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Louisiana State Employees Retirement System reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 33,600 Organogenesis Holdings shares in Q1 2023, an estimated $90K.
  • Louisiana State Employees Retirement System first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
  • Louisiana State Employees Retirement System's Organogenesis Holdings position peaked at $433K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q1 2023, filed 19 Apr 2023.